Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling.
Min, J.H., Yang, H., Ivan, M., Gertler, F., Kaelin Jr., W.G., Pavletich, N.P.(2002) Science 296: 1886-1889
- PubMed: 12004076 
- DOI: https://doi.org/10.1126/science.1073440
- Primary Citation of Related Structures:  
1LM8 - PubMed Abstract: 
The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel-Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability. pVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1alpha peptide-pVHL-ElonginB-ElonginC complex shows that HIF-1alpha binds to pVHL in an extended beta strand-like conformation. The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues. Although the beta sheet-like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic of signaling.
Organizational Affiliation: 
Cellular Biochemistry and Biophysics Program and Howard Hughes Medical Institute, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.